Alterations in the immunogenicity and antigenicity of mammalian erythrocytes following treatment with neuraminidase.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000921:Antibody-Producing Cells / Q000187:drug effects; D000941:Antigens; D002645:Chickens / Q000276:immunology; D004912:Erythrocytes / Q000187:drug effects / Q000276:immunology*; D006041:Goats / Q000276:immunology; D006462:Hemolytic Plaque Technique; D006736:Horses / Q000276:immunology; D006863:Hydrogen-Ion Concentration; D007114:Immunization; D051379:Mice; D008807:Mice, Inbred BALB C / Q000276:immunology; D009438:Neuraminic Acids / Q000494:pharmacology; D009439:Neuraminidase / Q000494:pharmacology*; D012756:Sheep / Q000276:immunology; D013154:Spleen / Q000276:immunology; D014734:Vibrio cholerae / Q000201:enzymology
D000941:Antigens; D009438:Neuraminic Acids; D009439:Neuraminidase